Here we have applied an in-depth quantitative proteomic approach [16]–[18] to the analysis of plasma protein changes related to tumor development in a K-ras/Pten ovarian cancer mouse model to determine their involvement in pathways and networks and their correspondence to proteins expressed or released from human ovarian cancer cells. The gene discussed is KRAS; the disease is ovarian carcinoma.